Entia Biosciences Inc (ERGO):企業の財務・戦略的SWOT分析

◆英語タイトル:Entia Biosciences Inc (ERGO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH185631FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Entia Biosciences Inc (EBI) is a biotechnology company that provides nutrigenomics solutions for organic health, beauty and agriculture. The company’s solution includes ErgoD2, mushroom dietary supplement, and multi joint support. It offers ErgoD2 solutions such as Ergo-D2-Hemo, Ergo-D2-FLEX-RA, and Ergo-D2-HSN. EBI’s Ergo-D2-Hemo is a medical nutrition solution used for treatment of diabetes and anemia; Ergo-D2-FLEX-RA is solution used to treat rheumatoid arthritis; and Ergo-D2-HSN is a nutrition solution that is used for treatment of alopecia and psoriasis. In addition, EBI provides products for nutritional management of autoimmune and neurodegenerative diseases. It offers identification, formulation, validation, and commercialization services. The company also serves food science and supplementation markets. EBI is headquartered in Sherwood, Oregon, the US.

This comprehensive SWOT profile of Entia Biosciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Entia Biosciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Entia Biosciences Inc – Key Information
Entia Biosciences Inc – Overview
Entia Biosciences Inc – Key Employees
Entia Biosciences Inc – Key Employee Biographies
Entia Biosciences Inc – Key Operational Heads
Entia Biosciences Inc – Major Products and Services
Entia Biosciences Inc – History
Entia Biosciences Inc – Company Statement
Entia Biosciences Inc – Locations And Subsidiaries
Entia Biosciences Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Entia Biosciences Inc – Business Description
Entia Biosciences Inc – Corporate Strategy
Entia Biosciences Inc – SWOT Analysis
SWOT Analysis – Overview
Entia Biosciences Inc – Strengths
Entia Biosciences Inc – Weaknesses
Entia Biosciences Inc – Opportunities
Entia Biosciences Inc – Threats
Entia Biosciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Entia Biosciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Entia Biosciences Inc, Key Information
Entia Biosciences Inc, Key Ratios
Entia Biosciences Inc, Share Data
Entia Biosciences Inc, Major Products and Services
Entia Biosciences Inc, History
Entia Biosciences Inc, Key Employees
Entia Biosciences Inc, Key Employee Biographies
Entia Biosciences Inc, Key Operational Heads
Entia Biosciences Inc, Other Locations
Entia Biosciences Inc, Subsidiaries
Entia Biosciences Inc, Key Competitors
Entia Biosciences Inc, SWOT Analysis
Entia Biosciences Inc, Ratios based on current share price
Entia Biosciences Inc, Annual Ratios
Entia Biosciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Entia Biosciences Inc (ERGO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Olmsted Medical Center-製薬・医療分野:企業M&A・提携分析
    Summary Olmsted Medical Center (OMC) is a healthcare service provider that offers patient care and clinical research services. The center offers services in the areas of general surgery, podiatry, pain management, dermatology, plastic surgery, inpatient dietary services, pediatrics, diabetes educati …
  • Europa Oil & Gas (Holdings) plc (EOG):企業の財務・戦略的SWOT分析
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Myer Holdings Ltd:戦略・SWOT・企業財務分析
    Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Myer Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fluidigm Corp (FLDM)-医療機器分野:企業M&A・提携分析
    Summary Fluidigm Corp (Fluidigm) formerly known as Mycometrix Corporation, is a biotechnology company which manufactures life-science tools and creates technologies based on microfluidics and mass cytometry. The company’s products systems include biomark HD system, access array system, C1 system, ca …
  • Quadra – Power Generation (TGKD):企業の財務・戦略的SWOT分析
    Quadra - Power Generation (TGKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Consol Energy Inc (CNX)-石油・ガス分野:企業M&A・提携分析
    Summary CONSOL Energy Inc. (CONSOL Energy) is an integrated energy company that produces natural gas and coal. It carries out coal bed methane extraction, conventional and shale gas exploration and production. The company operates, develops and explores for natural gas primarily in the Appalachia ba …
  • J.L. Clark Inc:企業の戦略的SWOT分析
    J.L. Clark Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Leap Therapeutics Inc (LPTX):医療機器:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • Korea Electric Power Corporation:企業の戦略・SWOT・財務情報
    Korea Electric Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Korea Electric Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Domestic & General Group Holdings Limited:企業の戦略・SWOT・財務情報
    Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Helix Resources Ltd (HLX):企業の財務・戦略的SWOT分析
    Summary Helix Resources Ltd (HRL) operates as a mining and mineral exploration company. The company carries out the business of identification, acquisition, and development of mineral properties. It explores gold, copper, zinc, uranium, nickel, and iron ore properties. HRL's projects include Colleri …
  • OncoSil Medical Ltd (OSL)-製薬・医療分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • Harley-Davidson, Inc.:企業の戦略・SWOT・財務分析
    Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report Summary Harley-Davidson, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • United Gulf Bank (B.S.C.)
    United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report Summary United Gulf Bank (B.S.C.) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oi S.A.:企業の戦略・SWOT・財務情報
    Oi S.A. - Strategy, SWOT and Corporate Finance Report Summary Oi S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Dentsu, Inc.:企業の戦略・SWOT・財務分析
    Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsu, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Panasonic Corp (6752)
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • PT Paninvest Tbk:企業の戦略・SWOT・財務情報
    PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Paninvest Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Lumos Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Lumos Pharma Inc (Lumos Pharma) is a developer of novel therapies for the treatment of rare and neglected diseases. The company’s pipeline product includes LUM-001, LUM-201 and LUM-301. Its lead compound LUM001, is a small and planar molecule used for the treatment of rare disease, creatine …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆